108
Participants
Start Date
October 31, 2015
Primary Completion Date
April 30, 2017
Study Completion Date
June 30, 2017
CHAM
The treatment indication is for chronic diabetic foot ulcers that can accommodate up to one 5cm x 5cm piece of CHAM
Control
Standard of Care
NSLIJHS, Lake Success
University Orthopedics, Altoona
Temple University, Philadelphia
MedStar Georgetown University Hospital, Washington D.C.
UNC, Chapel Hill
Duke University, Durham
Spartanburg Regional Healthcare System, Spartanburg
Barry University Clinical Research, North Miami Beach
Cleveland Clinic, Cleveland
North Texas Podiatric Medicine and Surgery Associates, Dallas
Texas Gulf Coast Medical Group, Webster
SAVAHCS, Tucson
ILD Research Center, Carlsbad
Center for Clinical Research, San Francisco
Stanford University, Stanford
Center for Clinical Research, Castro Valley
SSH, South Weymouth
Ocean County Foot & Ankle Surgical Associates, Toms River
Lead Sponsor
Osiris Therapeutics
INDUSTRY